Trials / Completed
CompletedNCT02043145
Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) in Korea
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 727 (actual)
- Sponsor
- Allergan · Industry
- Sex
- —
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This post marketing surveillance study in Korea will evaluate the safety and efficacy of BOTOX (botulinum toxin Type A) in patients who receive treatment according to standard of care for primary axillary hyperhidrosis, focal spasticity or moderate to severe glabellar lines in clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | botulinum toxin Type A | Botulinum toxin Type A (BOTOX®) as prescribed according to standard of care in clinical practice. |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2012-04-01
- Completion
- 2012-04-01
- First posted
- 2014-01-23
- Last updated
- 2014-06-13
- Results posted
- 2014-06-13
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02043145. Inclusion in this directory is not an endorsement.